Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN41133247
ISRCTN41133247CompletedNot Applicable

Subconjunctival steroid depot after cataract extractio

The Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (OZR) (The Netherlands)0 sites400 target enrollmentStarted: December 28, 2006Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
400
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Cataract extraction indication
  • •2. Aged over 18 years
  • •3. Caucasian - informed consent
  • •4. Post-op follow-up must be feasible

Exclusion Criteria

  • •1. Subcapsular posterior cataract (very soft, short phaco time)
  • •2. Brunescens or mature cataract (hard, long phaco time)
  • •3. Diabetes mellitus
  • •4. Age-related macula degeneration
  • •5. History of uveitis
  • •6. Glaucoma
  • •7. History of steroid response
  • •8. Per-operative iris manipulation (e.g. miosis or posterior synechiae)
  • •9. Pre-operative synechiae anterior
  • •10. Systemic steroid medication
  • •11. Chemotherapy
  • •12. Peroperative contact with vitreous
  • •13. Sickle cell anemia
  • •14. Corneal complications
  • •16. Herpes Simplex Virus (HSV)

Investigators

Sponsor
The Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (OZR) (The Netherlands)

Similar Trials

Completed
Not Applicable
Subconjunctival steroid depot after cataract extraction.Cataract.
NL-OMON24307Oogziekenhuis RotterdamSchiedamsevest 1803011 BH Rotterdam400
Completed
Not Applicable
To determine the efficacy of subacromial bursa corticosteroid injection in stroke patients with periarticular shouder disorder.Diseases of the musculo-skeletal system and connective tissue
KCT0000104Ajou University Hospital60
Not yet recruiting
Unknown
A clinical study to determine the safety and performance of Everads Injector for Injection of triamcinolone acetonide in suprachoroidal space of eye.
CTRI/2024/01/061410Everads Therapy Ltd.
Completed
Not Applicable
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract SurgeryIntraocular Inflammation
NCT01384266Associated Eye Care, Minnesota90
Recruiting
Not Applicable
Combined subconjunctival Atropine and intracameral epinephrine for pupil dilation in phacoemulsification .A comparative study .cataractEye DiseasesSurgery
PACTR201608001739424Dar El Oyoun hospital40